Desquamative interstitial pneumonia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Desquamative interstitial pneumonia
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Cough, dyspnea
Complications	Pulmonary fibrosis
Onset	Typically adulthood
Duration	Chronic
Types	N/A
Causes	Smoking, environmental exposure
Risks	Cigarette smoking
Diagnosis	HRCT, lung biopsy
Differential diagnosis	Usual interstitial pneumonia, nonspecific interstitial pneumonia
Prevention	N/A
Treatment	Smoking cessation, corticosteroids
Medication	N/A
Prognosis	Variable, can progress to pulmonary fibrosis
Frequency	Rare
Deaths	N/A

Desquamative interstitial pneumonia (DIP) is a form of interstitial lung disease characterized by the accumulation of inflammatory cells and fibrosis within the lung tissue. It is considered a rare disease and primarily affects adults, particularly smokers. The condition was first described in 1965 by Liebow and Carrington.

Signs and Symptoms

Patients with DIP often present with symptoms such as shortness of breath, cough, and fatigue. These symptoms are nonspecific and can be seen in other lung diseases as well. In some cases, patients may also experience weight loss and chest pain. It is important to note that the severity of symptoms can vary among individuals.

Causes and Risk Factors

The exact cause of DIP is unknown, but it is strongly associated with smoking. Studies have shown that the majority of patients diagnosed with DIP are current or former smokers. Other risk factors include exposure to environmental toxins and certain occupational hazards.

Diagnosis

The diagnosis of DIP involves a combination of clinical evaluation, radiological imaging, and histopathological examination. High-resolution computed tomography (HRCT) scans of the chest can reveal characteristic findings such as ground-glass opacities and consolidation. However, a definitive diagnosis requires a lung biopsy, which typically shows the presence of macrophages within the alveoli.

Treatment

The primary treatment for DIP is smoking cessation. Quitting smoking can help slow down the progression of the disease and improve lung function. In addition, patients may be prescribed corticosteroids to reduce inflammation and manage symptoms. Oxygen therapy may also be necessary in cases of severe respiratory impairment.

Prognosis

The prognosis for DIP varies depending on the individual and the stage of the disease at the time of diagnosis. With early detection and appropriate treatment, some patients may experience a significant improvement in lung function and quality of life. However, in advanced cases, the prognosis may be poor, with a higher risk of developing complications such as respiratory failure.

See Also

• Interstitial lung disease
• Smoking cessation
• High-resolution computed tomography
• Lung biopsy

External Links

• Desquamative Interstitial Pneumonia - StatPearls
• Desquamative Interstitial Pneumonia - Radiopaedia